KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Common Equity (2016 - 2025)

Humana (HUM) has disclosed Common Equity for 16 consecutive years, with $17.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity changed N/A to $17.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $17.7 billion, a N/A change, with the full-year FY2025 number at $17.7 billion, changed N/A from a year prior.
  • Common Equity was $17.7 billion for Q4 2025 at Humana, down from $18.6 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $18.6 billion in Q3 2025 to a low of $14.2 billion in Q1 2021.
  • A 4-year average of $16.5 billion and a median of $16.3 billion in 2022 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: increased 17.3% in 2021, then decreased 4.55% in 2022.
  • Humana's Common Equity stood at $16.1 billion in 2021, then fell by 4.55% to $15.4 billion in 2022, then increased by 10.63% to $17.0 billion in 2023, then increased by 3.84% to $17.7 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Common Equity are $17.7 billion (Q4 2025), $18.6 billion (Q3 2025), and $18.3 billion (Q2 2025).